ARCHIVES

NDA For MeCCNU Turned Down By Oncologic Drugs Advisory Committee

This article is from The Cancer Letter archive.

Vol. 02 No. 36 | September 3, 1976

Download PDF Visit The Full Archive

Related Articles

Finasteride For Prostate Cancer Prevention Causes Little Or No Sexual Dysfunction

August 31, 2007

Evidence Supports Screening Younger Women, Expert Says

September 24, 1993

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012

In Brief: HHS Rejects Sole Source Award For Utah Study; Reagan Proclaims April Cancer Control Month

April 3, 1981

Phase III BETH Study Combining Avastin And Herceptin Open For Enrollment

June 27, 2008

In Brief: FDA Advisors Ask Cetus To Refine IL-2 Application; NIH Reauthorization Introduced

August 3, 1990